Literature DB >> 10769781

Solubility and dissolution properties of generic rifampicin raw materials.

S Q Henwood1, M M de Villiers, W Liebenberg, A P Lötter.   

Abstract

Rifampicin shows polymorphism; therefore, it is necessary to select a suitable crystal form at an early stage of development to ensure optimum solubility and dissolution rates. This study was an investigation into the crystal properties of several rifampicin raw materials currently being used by manufacturers of generic rifampicin raw materials in South Africa. Powders were characterized by X-ray diffraction (XRD), infrared (IR) spectroscopy, and differential scanning calorimetry (DSC). The solubility in water and dissolution properties in water, buffer pH 7.4 and 0.1 M HCl, were also measured. The main difference between the powders was the amorphous content. XRD, IR, and DSC methods could detect the presence of amorphous rifampicin. In contrast to expectations, an increase in amorphous content significantly reduced the dissolution rate of the powders in water and buffer pH 7.4. This behavior was attributed to the electrostatic properties of the very fine particles in the amorphous powders. The results of this study showed that the physical properties of rifampicin raw materials varied not only among manufacturers, but also among batches from the same manufacturer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10769781     DOI: 10.1081/ddc-100101246

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  8 in total

1.  Elucidating the role of dose in the biopharmaceutics classification of drugs: the concepts of critical dose, effective in vivo solubility, and dose-dependent BCS.

Authors:  Georgia Charkoftaki; Aristides Dokoumetzidis; Georgia Valsami; Panos Macheras
Journal:  Pharm Res       Date:  2012-07-04       Impact factor: 4.200

2.  Rifaximin for the treatment of acute infectious diarrhea.

Authors:  Kyoung Sup Hong; Joo Sung Kim
Journal:  Therap Adv Gastroenterol       Date:  2011-07       Impact factor: 4.409

3.  Impact of the antibiotic-cargo from MSNs on Gram-positive and Gram-negative bacterial biofilms.

Authors:  Anna Aguilar-Colomer; Montserrat Colilla; Isabel Izquierdo-Barba; Carla Jiménez-Jiménez; Ignacio Mahillo; Jaime Esteband; María Vallet-Regí
Journal:  Microporous Mesoporous Mater       Date:  2020-10-07       Impact factor: 5.876

4.  Effectiveness, safety and cost of drug substitution in hypertension.

Authors:  Atholl Johnston; Panagiotis Stafylas; George S Stergiou
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

5.  Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing.

Authors:  Wyatt J Roth; Candice B Kissinger; Robyn R McCain; Bruce R Cooper; Jeremy N Marchant-Forde; Rachel C Vreeman; Sophia Hannou; Gregory T Knipp
Journal:  AAPS J       Date:  2013-04-18       Impact factor: 4.009

6.  Bioavailability of two licensed paediatric rifampicin suspensions: implications for quality control programmes.

Authors:  H McIlleron; H Hundt; W Smythe; A Bekker; J Winckler; L van der Laan; P Smith; H J Zar; A C Hesseling; G Maartens; L Wiesner; A van Rie
Journal:  Int J Tuberc Lung Dis       Date:  2016-07       Impact factor: 2.373

7.  Solid-state characterization of nevirapine.

Authors:  Mahua Sarkar; O P Perumal; R Panchagnula
Journal:  Indian J Pharm Sci       Date:  2008-09       Impact factor: 0.975

8.  Can small drugs predict the intrinsic aqueous solubility of 'beyond Rule of 5' big drugs?

Authors:  Alex Avdeef; Manfred Kansy
Journal:  ADMET DMPK       Date:  2020-04-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.